Somatomedin B
Showing 1 - 25 of >10,000
COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for
Not yet recruiting
- COVID-19
- SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
- SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
-
Manila, Philippines
- +2 more
Jun 21, 2023
COVID-19 Pandemic Trial in Dubai (PIKA COVID-19 Vaccine (CHO cell, S-protein), Arm A, PIKA COVID-19 Vaccine (CHO cell,
Active, not recruiting
- COVID-19 Pandemic
- PIKA COVID-19 Vaccine (CHO cell, S-protein), Arm A
- PIKA COVID-19 Vaccine (CHO cell, S-protein), Arm B
-
Dubai, United Arab EmiratesAl Kuwait Hospital (Al Baraha Hospital)
Mar 29, 2022
Covid19 Vaccine Trial in Taiwan (MVC-COV1901(S protein with adjuvant))
Active, not recruiting
- Covid19 Vaccine
- MVC-COV1901(S protein with adjuvant)
-
Changhua, Taiwan
- +10 more
Jun 13, 2022
Covid19 Vaccine Trial in Taiwan, Vietnam (MVC-COV1901(S protein with adjuvant), MVC-COV1901(Saline))
Completed
- Covid19 Vaccine
- MVC-COV1901(S protein with adjuvant)
- MVC-COV1901(Saline)
-
Changhua, Taiwan
- +11 more
Jan 27, 2022
Pertussis/Whooping Cough Trial in Southampton (Bordetella pertussis B1917, Azithromycin Pill)
Recruiting
- Pertussis/Whooping Cough
- Bordetella pertussis B1917
- Azithromycin Pill
-
Southampton, Hampshire, United KingdomNIHR Clinical Research Facility
Apr 26, 2023
Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene
Recruiting
- Hepatitis B, Chronic
- genotyping
-
Sohag, EgyptSohag university Hospital
Sep 4, 2023
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
Total Knee Replacement, Knee Arthroplasty Trial in New Haven (Bupivacaine-Liposomal Bupivacaine, Bupivacaine -Dexamethasone
Recruiting
- Total Knee Replacement
- Knee Arthroplasty
- Bupivacaine-Liposomal Bupivacaine
- Bupivacaine -Dexamethasone Sodium Phosphate-Methylprednisolone Acetate
-
New Haven, Connecticut
- +1 more
Feb 17, 2023
COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)
Completed
- COVID-19
- Influenza
- Lucira COVID-19 & Flu Test
-
Cullman, Alabama
- +6 more
Nov 16, 2023
Tenofovir Disoproxil Fumarate and Entcavir in Treatment of
Recruiting
- Chronic Hepatitis b Patients
- Tenofovir Disoproxil Fumarate and Entcavir
-
Sohag, EgyptSohag University hospitals
May 22, 2023
Drug-Induced Nephropathy Trial in Cairo (N Acetylcysteine)
Recruiting
- Drug-Induced Nephropathy
- N Acetylcysteine
-
Cairo, EgyptHelwan University
Nov 7, 2023
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)
Recruiting
- B-Cell Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2023
B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)
Not yet recruiting
- B-cell Acute Lymphoblastic Leukemia
- HY004
- +2 more
- (no location specified)
Aug 18, 2023
Epithelial Lining Fluid and Blood Pharmacokinetics and
Recruiting
- Polymyxin B
- +3 more
- nebulized polymyxin B
-
Nanjing, Jiangsu, ChinaZhongda Hospital Affiliated to Southeast University
Oct 7, 2023
JAK-i on RA B-lymphocytes Tolerance and Disease Resolution
Recruiting
- Rheumatoid Arthritis
- B lymphocyte profiling
-
Rome, ItalyDivision of Clinical Immunology, Fondazione Policlinico Universi
Feb 22, 2023
Hypothermia's Effect on Hepatitis B Vaccination
Not yet recruiting
- Hypoxic-Ischemic Encephalopathy
- +2 more
- Hypothermia Protocol
- (no location specified)
Mar 15, 2023
Non-hodgkin Lymphoma Trial (HY004)
Not yet recruiting
- Non-hodgkin Lymphoma
- HY004
- (no location specified)
Aug 21, 2023
SARS-CoV2 Infection, Covid19, SARS-CoV-2 Acute Respiratory Disease Trial in Worldwide (BNT162b2, BNT162b2 (B.1.1.7 + B.1.617.2),
Active, not recruiting
- SARS-CoV2 Infection
- +3 more
- BNT162b2
- +5 more
-
Long Beach, California
- +34 more
Jan 10, 2023
Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))
Recruiting
- Hematologic Malignancy
- B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
-
Duarte, CaliforniaCity of Hope
Oct 20, 2023
Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)
Recruiting
- Non-hodgkin Lymphoma
- +2 more
- CC312
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 12, 2023
Healthy Trial in Shenyang (HSK7653(5mg), HSK7653(25mg))
Completed
- Healthy
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of Liaoning University of Traditio
Aug 22, 2023
Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)
Recruiting
- Hemophilia B
- Sodium valproate extended-release tablets
-
Beijing, ChinaPLA General Hospital
Jun 17, 2023